The fight against falsified medicines has just started: What comes after serialization?


As security experts, but also as consumers, a unique approach on how pharmaceutical companies could benefit from digital innovation.

As we reached the deadline for the implementation of serialization of medicines in the EU, it is time to ask how efficient these measures could be to eradicate falsified medicines. And whether they will make patients safer and more confident about their medicines.

As an expert in security solutions and leading player in digital authentication, Arjo Solutions proposes in this white paper a comprehensive approach on how pharmaceutical companies could increase drugs integrity and patients safety.

Complete this form, you will then receive an email in your mailbox, allowing you to download the white paper